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Enterovirus D68 (EV-D68), phylogenetic clade B was 
identified in nasopharyngeal specimens of two cases 
of severe acute flaccid myelitis. The cases were six 
and five years-old and occurred in September and 
November 2014. EV-D68 is increasingly associated 
with acute flaccid myelitis in children, most cases 
being reported in the United States. Awareness of this 
possible neurological complication of enterovirus D68 
infection is needed.
An unexpectedly high proportion of children were 
admitted for severe respiratory infections at the Oslo 
University Hospital, Ullevål, Norway, during September 
and October, 2014 [1]. Enterovirus was detected in 66 
(22%) of 303 samples from children hospitalised with 
acute respiratory infection, and in five of 51 samples 
received from outpatient clinics. Enterovirus D68 (EV-
D68) was verified in 33 of the enterovirus-positive 
samples from hospitalised patients, and in one of the 
outpatients.
We report two cases of severe acute flaccid myelitis 
(AFM) associated with EV-D68 infection that occurred 
in September and November 2014 in Norway.
Case 1
A six year-old girl was referred to a paediatric depart-
ment in the Oslo area, Norway, on 20 September 2014. 
She was previously healthy and fully vaccinated accord-
ing to the Norwegian child vaccination programme, 
including polio vaccine. She reported a sore throat, 
neck pain, headache and occasional vomiting for two 
days. Fever (38.6 °C) occurred on the second day and 
she became increasingly tired with tachypnoea, cough-
ing and abdominal pain. She presented with a faint 
voice, reduced general condition, neck pain, but no 
nuchal rigidity. General and neurological examination 
was normal. Leucocyte count was 12.9 × 109 cells/L 
(norm: 5.0–15.5) with neutrophilocytes accounting for 
74%. C-reactive protein (CRP) was 4 mg/L (norm: 0.0–
4.0). Viral upper airway infection was suspected, but 
PCR analysis of a nasopharyngeal specimen was nega-
tive for common respiratory viruses, and the patient 
was discharged. She was readmitted two days later 
with further deteriorated general condition, general 
muscle weakness, mainly proximal and more severe 
in both upper extremities and neck, and weak/ absent 
deep tendon reflexes. A chest X-ray showed an atelec-
tasis in the left lower lobe but a lower respiratory spec-
imen was not secured. Severe respiratory failure, due 
to diaphragmatic paresis, resulted in respirator treat-
ment. Meningitis treatment with cefotaxime, ampicillin 
and aciclovir was started. Acute disseminated enceph-
alomyelitis (ADEM) was suspected, and methylpredni-
solone instituted.
Cerebrospinal fluid (CSF) pleocytosis (173 × 106 
cells/L (norm: 0–4), 94% mononuclear) and a slightly 
increased CSF protein concentration (0.45 g/L (norm: 
0.000–0.450)) were found on Day 4. On Day 6, before 
intravenous immunoglobulin infusion or plasmapher-
esis, only a slight pleocytosis (23 × 106 cells/L) was 
found, however, an increased IgG index indicated 
intrathecal IgG production but oligoclonal bands were 
not detected. CSF cell count had normalised on Day 44, 
with CSF protein still slightly increased (0.648 g/L).
PCR analyses of the CSF revealed no intrathecal her-
pes simplex virus, human herpes virus 6 or 7, varicella-
zoster virus, Epstein-Barr virus, cytomegalovirus, 
human parechovirus or enterovirus. Bacterial culture, 
including for Listeria monocytogenes, was negative. 
No intrathecal antibodies against Borrelia burgdorferi 
were detected. Serological analysis showed no infec-
tion with herpes simplex virus, varizella-zoster virus, 
Epstein-Barr virus, cytomegalovirus, Mycoplasma 
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pneumoniae, Borrelia burgdorferi, Cryptococcus neo-
formans or Mycobacterium tuberculosis. Two faecal 
specimens, collected on Days 21 and 22, showed no 
growth of enterovirus. Antibodies associated with 
autoimmune encephalitis could not be detected.
Magnetic resonance imaging (MRI) on Day 4 showed 
oedema of mainly grey matter in a longitudinal, trans-
verse pattern, extending from the pedunculi cerebri 
to the thoracolumbar level. Day 8 there was regres-
sion of the oedema, and MRI was normal on Day 44. 
Electroencephalography (EEG) was normal on Day 3 
and Day 16, but compatible with encephalitis/ enceph-
alopathy on Day 5.
Following reports from the United States (US) and 
Canada on EV-D68, a nasopharyngeal specimen taken 
on Day 2 was tested with a generic real-time RT-PCR 
for enteroviruses targeting the 5’ non-coding region, 
and was positive. Sequencing of the PCR product sug-
gested EV-D68, which was confirmed by a real-time 
RT-PCR EV-D68 assay (ct value < 30 cycles). PCR for 
EV-D68 was negative in serum (Days 4 and 12), faeces 
(Day 9) and CSF (Days 4 and 44), and in tracheal secre-
tion (Day 30).
The patient now walks steadily, but head control is 
poor. Motor impairment is worse proximally and still 
pronounced in the proximal upper extremities and 
neck where muscular atrophy is evident. She is partly 
fed through a gastrostomy tube and speaks with a thin 
voice.
Case 2
A five year-old girl was referred to a paediatric depart-
ment in the Oslo area, Norway, on 13 November 2014. 
She was previously healthy and fully vaccinated accord-
ing to the Norwegian child-vaccination programme, 
including polio vaccine. She had a history of upper air-
way infection, poor feeding and drinking, and fever up 
to 39.4 °C for 12 days. On Day 4 of the illness she com-
plained of neck and back pain. On Day 5, headaches, 
abdominal pain and vomiting occurred. On Day 6, she 
complained of stiffness of the neck. The family doctor 
found a reduced general condition, mild dehydration, 
but no nuchal rigidity. On Day 7, weakness occurred in 
the lower extremities, impairing gait, and the pain and 
general condition had worsened.
Upon examination at the hospital she was awake and 
alert, with panting tachypnoea. She was tachycardic 
(pulse: 161/min) and febrile (38.4 °C), other vital 
signs were normal. Neurological examination was 
normal. White blood cell count was 12.8 × 109 cells/L 
with 77% neutrophilocytes. CRP was 10 mg/L. A chest 
X-ray showed a pneumonic infiltrate. PCR analysis of 
a nasopharyngeal specimen was negative for com-
mon respiratory viruses. Erythromycin was instituted 
and the patient was discharged. PCR of a nasopharyn-
geal aspirate was negative for Mycoplasma pneumo-
niae and bacterial culture showed significant growth 
of Haemophilus influenzae. Lower respiratory sam-
ples were not secured. On Day 12, the patient was re-
admitted with increasing weakness of the left arm, gait 
difficulties, pain in the neck, left shoulder and both 
legs, most severely when extended. She had dysp-
noea, tachypnoea and panting. Brudzinski’s sign was 
positive and she presented flaccid paralysis grade 1–2 
of the left arm as well as weakness of neck muscles, 
she could not hold her head or walk unsupported. The 
patient hypoventilated since the diaphragm was partly 
paretic. Continuous positive airway pressure (CPAP) 
treatment and cough assist machine were instituted 
and intravenous immunoglobulin infusion was given.
A lumbar puncture revealed 14 × 106 cells/L, a protein 
level of 0.88 g/L and glucose of 4.4 mmol/L (norm: 
2.5–4.4).  There was no serological evidence of auto-
immune encephalitis. EV-D68 was detected in a naso-
pharyngeal specimen collected at Day 7, using a generic 
real-time RT-PCR (ct value < 30 cycles), however, culture 
was negative. EV-D68 was not found in stool (Day 18), 
serum (Day 15), or CSF (Day 15). CSF cultures (virus and 
bacteria) (Day 15) were negative. An MRI scan on Day 15 
showed cervical central medullary oedema and on Day 
20 grey matter oedema at cervical and thoracic level, 
representing myelitis, as well as radiculitis in the lum-
bar region. Neurography supported the diagnosis of 
acute anterior myelitis.
The outcome is with severe paresis and atrophy in the 
proximal left arm and left upper limb girdle.
Sequence analysis for Case 1
PCR for sequencing was performed as described in Nix 
et al. [2]. Sequencing was not possible in for Case 2, 
due to low amounts of virus and insufficient sample 
material. The sequence from Case 1 was aligned with 
the sequences of one reported AFM case from 2014 in 
France as well as other European strains, including the 
majority of the 16 Norwegian EV-D68 cases identified 
in autumn 2014 (Figure) [1].
Discussion
EV-D68 is mainly associated with respiratory disease 
and was first isolated in California in 1962 from chil-
dren with airway infection [3,4]. Until 2009, EV-D68 
was rarely isolated [5]. Since then, outbreaks of res-
piratory disease with EV-D68 have occurred world-
wide [6-9]. EV-D68 infections in the Dutch population 
is increasing [10]. In autumn 2014, EV-D68 was found 
in 11% of children hospitalised for airway infection in 
the Oslo region [1]. Of the 34 patients, 32 were younger 
than seven years.
During an outbreak of respiratory EV-D68-disease 
in the US in autumn 2014, nine children presented 
with AFM; EV-D68 was detected in four of eight naso-
pharyngeal specimens [11]. From 2 August 2014 to 2 
March 2015, the American Centers for Disease Control 
and Prevention (CDC) verified reports of 115 children 
in 34 US states who developed AFM. These cases are 
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Figure
Phylogenetic cluster analysis of enterovirus D68 partial VP1 sequences (207 nt) from an acute flaccid myelitis case, Norway, 
September 2014 
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Viruses are named with GenBank accession numbers followed by 
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currently being investigated [12]. A single European 
case of EV-D68-associated AFM is reported [13]. This 
virus was of Clade B, closely related to Dutch, Spanish 
and Italian types from 2009 to 2014. From outbreaks 
in Asia and Australia, enterovirus-71 (EV-A species) 
is known to cause AFM [14,15]. However EV-D68 has 
rarely been reported to cause AFM, and almost never 
been isolated from CSF [5,14].
In the two AFM cases we report here, the virus was 
only detected in the early nasopharyngeal specimens, 
highlighting the importance of obtaining this specimen 
early. Pleocytosis, increased intrathecal IgG index, 
increased CFS-proteins, spinal grey matter-oedema 
and denervation on neurophysiology may indicate 
direct CNS infection and neuron destruction. A causal 
relation is however not proven since no direct evi-
dence of EV-D68 infection in the CNS has been found. 
Detection of EV-D68-virus may have been coincidental 
and due to the high incidence of the virus [9]. However, 
the two cases share striking clinical and imaging simi-
larities [16] and no other pathogen has been detected. 
Intrathecal EV-D68 antibody detection would be indica-
tive of EV-D68 being the neurotrophic pathogen, how-
ever this analysis is not available in our hospital and 
was therefore not performed.
Sequencing of the VP1 gene obtained from Norwegian 
cases showed a similar genotype in the AFM case and 
non-AFM cases. While a statistical increase is difficult 
to prove for such a rare disease, the authors are of the 
opinion that there is an increase in AFM cases associ-
ated with enterovirus D-68 as has been reported from 
the US [17]. On basis of our findings we can speculate 
that this may not be caused by increased neurotrophy 
in a single genotype, but perhaps due to an increased 
number of EV-D68-infected individuals. It is possible, 
however, that mutations in non-VP1 regions are respon-
sible for increased neurotrophy.
As we found an identical VP1-sequence in Case 1 and 
in a child with solely respiratory disease, host-related 
factors are likely to be of importance for the individual 
risk of developing AFM. At least three different EV-D68 
strains were circulating in Norway in the autumn of 
2014, suggesting three separate introductions. No dif-
ferences in the partial sequence of the VP1 region were 
observed between the AFM case and non-AFM cases.
International collaboration is needed to confirm the 
association between EV-D68 and AFM, and to achieve 
knowledge on treatment and outcome. It is impor-
tant to recognise this disease, which may become 
life-threatening.
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